Tuesday, May 11, 2021
Home Life Style Health & Fitness Chinese Alzheimer's Drug to Undergo Global Clinical Trials

Chinese Alzheimer’s Drug to Undergo Global Clinical Trials

In the last test, a total of 818 participants from 34 leading hospitals in China took 450 mg GV-971 orally twice a day for a treatment period of nine months, which proved safe and effective in improving cognition

An innovative Chinese Alzheimer’s drug extracted from brown algae is set to go through clinical trials on 2,000 patients overseas this year.

The orally administered drug GV-971 will be tested in 200 clinical centers in North America, the European Union, Eastern Europe, Asia Pacific and other places, according to Green Valley Pharmaceutical Company, one of the drug’s co-developers.

China has already approved the drug.

Green Valley Pharmaceutical will complete the global clinical trials in 2024 and submit the New Drug Application to the US Food and Drug Administration and European Medicines Agency in 2025, Xinhua reported.

GV-971 was jointly developed by the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences (CAS), Ocean University of China and Green Valley, after a 22-year study.

Alzheimer's
A lady suffering from Alzheimer’s. Flickr

The results of the mechanism of action study were published in the international journal Cell Research in September 2019, saying that the drug works by modifying gut bacteria to ultimately reduce brain inflammation in mice that were genetically engineered to have the disease.

It was approved for marketing last November by China’s National Medical Products Administration, which said the GV-971 “can improve cognition in patients with mild to moderate Alzheimer’s disease (AD).”

Also Read: NASA Loses Contact with Satellite to Study Distant Planets: Report

According to researchers, apart from animal experiments, more than 1,100 Chinese Alzheimer’s disease patients participated in clinical trials before the drug hit the market.

In the last test, a total of 818 participants from 34 leading hospitals in China took 450 mg GV-971 orally twice a day for a treatment period of nine months, which proved safe and effective in improving cognition.

“Because of its effectiveness on Chinese patients, we expect this drug to benefit more people in the rest of the world,” said Lyu Songtao, Chairman of the Shanghai-based pharmaceutical company. (IANS)

STAY CONNECTED

19,511FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

Knowledge Sharing Social Media Platform For Medical Students: MedBound

We've already been using major social networking sites for different purposes. Well, there are also some social networking sites that aren't to be missed...

Covid19 In India Brought Automation Technologies And IA To The Forefront

The Covid-19 pandemic has brought automation technologies to the forefront and the Intelligent Automation (IA) market in India is estimated to grow at a...

Corset: A Brief History

By- Khushi Bisht Corsets have existed for a very long time. It first originated in Italy and was brought to France in the 16th century...

Hybrid Work Is The Next Big Disruption In US Society

By Dora Mekouar Hybrid schedules could be the next monumental shift in the American workplace after last year's sudden move to remote work. More than 70%...

An Overview Of Bipolar Disorder

BY- JAYA CHOUDHARY Bipolar disorder, also known as bipolar depressive disorder, is a neurological disorder that causes mood and behavior changes. Bipolar disorder is characterized...

Cancer Immunotherapy Approach Targets Common Genetic Alteration

By Blake Jones Researchers have found a prototype for a new kind of immunotherapy for cancer. This therapy uses modified T-cells to target and attack...

Outlook Into Wellness Tourism Growth During Pandemic

The roller coaster ride that was 2020 brought the biggest dip in modern history, forcing individuals to adapt to major lifestyle changes while the...

Strengthen Your Immune System Against Foreign Pathogens

At the personal level, the fight against the Covid-19 virus begins with strong immunity. As the second wave turns out to be more alarming...

Recent Comments